Published in
Elsevier, Journal of Allergy and Clinical Immunology, 3(141), p. 1002-1008
DOI: 10.1016/j.jaci.2017.07.036
Links
Tools
Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen–related apple allergy
Journal article published in 2018 by
Tamar Kinaciyan,
Birgit Nagl,
Sandra Faustmann,
Florian Frommlet,
Stephan Kopp,
Martin Wolkersdorfer,
Stefan Wöhrl 
,
Hans Huber,
Katharina Bastl,
Uwe Berger,
Barbara Bohle
,
Hans Huber,
Katharina Bastl,
Uwe Berger,
Barbara Bohle
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 